Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Provention Bio, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
PRVB is no longer listed, so this page shows Q1 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 183
- +50 vs. Q4 2022
- Shares held
- 60.6M
- +15.4M (+34.2%) vs. Q4 2022
- Total value
- $1.47B
- +$991.6M (+207.7%) vs. Q4 2022
- New holders
- 77
- 52 more added
- Sold out
- 27
- 35 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $2.80M |
| Q1 2023 | 183 | $1.47B |
| Q4 2022 | 133 | $477.4M |
| Q3 2022 | 112 | $187.1M |
| Q2 2022 | 115 | $99.9M |
| Q1 2022 | 113 | $177.0M |
| Q4 2021 | 112 | $133.0M |
| Q3 2021 | 115 | $142.9M |
| Q2 2021 | 125 | $196.9M |
| Q1 2021 | 120 | $249.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Provention Bio, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −12,920−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −2,970−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,120−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −1,411−100.0% | Sold out |
| Plante Moran Financial Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Providence Capital Advisors, LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |